Patents by Inventor Richard MORPHY

Richard MORPHY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 12630516
    Abstract: The invention relates to compounds of formula (I): and related aspects.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: May 19, 2026
    Assignee: NRG THERAPEUTICS LTD.
    Inventors: Neil Miller, Richard Rutter, Jan Kulagowski, Richard Morphy, Tammy Ladduwahetty, John Maclean, Mustafa Moroglu, Eric Talbot, Michael Rowley
  • Acrylamide derivatives
    Patent number: 12497359
    Abstract: The invention relates to compounds of formula (I) and related aspects.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: December 16, 2025
    Assignee: NRG THERAPEUTICS LTD
    Inventors: Neil Miller, Richard Rutter, Jan Kulagowski, Richard Morphy, Tammy Ladduwahetty, John MacLean, Eric Talbot
  • ACRYLAMIDE COMPOUNDS
    Publication number: 20250179028
    Abstract: The invention relates to compounds of formula (I): (I) and related aspects.
    Type: Application
    Filed: March 2, 2023
    Publication date: June 5, 2025
    Applicant: NRG THERAPEUTICS LTD
    Inventors: Neil MILLER, Richard RUTTER, Jan KULAGOWSKI, Richard MORPHY, Tammy LADDUWAHETTY, John MACLEAN, Mustafa MOROGLU, Eric TALBOT, Michael ROWLEY, Christopher G. THOMSON
  • NOVEL COMPOUNDS
    Publication number: 20240067614
    Abstract: The invention relates to compounds of formula (I): and related aspects.
    Type: Application
    Filed: September 1, 2021
    Publication date: February 29, 2024
    Applicant: NRG Therapeutics Ltd.
    Inventors: Neil MILLER, Richard RUTTER, Jan KULAGOWSKI, Richard MORPHY, Tammy LADDUWAHETTY, John MACLEAN, Mustafa MOROGLU, Eric TALBOT, Michael ROWLEY
  • NOVEL COMPOUNDS
    Publication number: 20230312466
    Abstract: The invention relates to compounds of formula (I) and related aspects.
    Type: Application
    Filed: September 1, 2021
    Publication date: October 5, 2023
    Applicant: NRG Therapeutics Ltd
    Inventors: Neil MILLER, Richard RUTTER, Jan KULAGOWSKI, Richard MORPHY, Tammy LADDUWAHETTY, John MACLEAN, Eric TALBOT